CTOR SCHEDULE 13G/A: SEC filing

Armistice Capital, LLC

Filed with the SEC on · accession 0001172661-26-005218

CTOR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -6.8% by the first close after the filing.

Summary of the filing

Armistice Capital, LLC filed an amended Schedule 13G reporting beneficial ownership of 9,394,202 shares (9.99%) of Citius Oncology, Inc. common stock as of September 30, 2026, held through Armistice Capital Master Fund Ltd.

Key details

Shares beneficially owned$9.4M
Percent of class owned$10
Reporting person / investment managerArmistice Capital, LLC
Direct holder of the sharesArmistice Capital Master Fund Ltd.
IssuerCitius Oncology, Inc.
Managing member of armistice capital, llcSteven Boyd

How CTOR stock reacted

Close before

$0.57

Nov 13, 2026

First close after

-6.76%

$0.54

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CTOR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CTOR?

Click here

Frequently asked questions

What did CTOR file with the SEC on Nov 16, 2026?

CTOR filed a SCHEDULE 13G/A (SEC filing). Armistice Capital, LLC filed an amended Schedule 13G reporting beneficial ownership of 9,394,202 shares (9.99%) of Citius Oncology, Inc. common stock as of September 30, 2026, held through Armistice Capital Master Fund Ltd.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CTOR stock react to this filing?

CTOR closed at $0.57 before the filing and $0.54 on Nov 16, 2026 (-6.76%).

Other CTOR SEC filings

Get alerts when CTOR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days